BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

520 related articles for article (PubMed ID: 34685574)

  • 21. Regulatory chaperone complexes in neurodegenerative diseases: a perspective on therapeutic intervention.
    Carman A; Kishinevsky S; Koren J; Luo W; Chiosis G
    Curr Alzheimer Res; 2014 Jan; 11(1):59-68. PubMed ID: 24251390
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Hsp70-Hsp90 Chaperone Cascade in Protein Folding.
    Morán Luengo T; Mayer MP; Rüdiger SGD
    Trends Cell Biol; 2019 Feb; 29(2):164-177. PubMed ID: 30502916
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Model systems of protein-misfolding diseases reveal chaperone modifiers of proteotoxicity.
    Brehme M; Voisine C
    Dis Model Mech; 2016 Aug; 9(8):823-38. PubMed ID: 27491084
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hsp90 regulates tau pathology through co-chaperone complexes in Alzheimer's disease.
    Salminen A; Ojala J; Kaarniranta K; Hiltunen M; Soininen H
    Prog Neurobiol; 2011 Jan; 93(1):99-110. PubMed ID: 21056617
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Applying chaperones to protein-misfolding disorders: molecular chaperones against α-synuclein in Parkinson's disease.
    Chaari A; Hoarau-Véchot J; Ladjimi M
    Int J Biol Macromol; 2013 Sep; 60():196-205. PubMed ID: 23748003
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of hippocampal neuronal resilience during aging by the Hsp70/Hsp90 co-chaperone STI1.
    Lackie RE; Razzaq AR; Farhan SMK; Qiu LR; Moshitzky G; Beraldo FH; Lopes MH; Maciejewski A; Gros R; Fan J; Choy WY; Greenberg DS; Martins VR; Duennwald ML; Lerch JP; Soreq H; Prado VF; Prado MAM
    J Neurochem; 2020 Jun; 153(6):727-758. PubMed ID: 31562773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chaperone signalling complexes in Alzheimer's disease.
    Koren J; Jinwal UK; Lee DC; Jones JR; Shults CL; Johnson AG; Anderson LJ; Dickey CA
    J Cell Mol Med; 2009 Apr; 13(4):619-30. PubMed ID: 19449461
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The neurodegenerative-disease-related protein sacsin is a molecular chaperone.
    Anderson JF; Siller E; Barral JM
    J Mol Biol; 2011 Aug; 411(4):870-80. PubMed ID: 21726565
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular chaperones biochemistry and role in neurodegenerative diseases.
    Chaari A
    Int J Biol Macromol; 2019 Jun; 131():396-411. PubMed ID: 30853582
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tau protein aggregates inhibit the protein-folding and vesicular trafficking arms of the cellular proteostasis network.
    Yu A; Fox SG; Cavallini A; Kerridge C; O'Neill MJ; Wolak J; Bose S; Morimoto RI
    J Biol Chem; 2019 May; 294(19):7917-7930. PubMed ID: 30936201
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Emerging Roles of Extracellular Chaperones in Complement Regulation.
    Geraghty NJ; Satapathy S; Wilson MR
    Cells; 2022 Dec; 11(23):. PubMed ID: 36497163
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hsp90 Chaperones Bluetongue Virus Proteins and Prevents Proteasomal Degradation.
    Mohl BP; Roy P
    J Virol; 2019 Oct; 93(20):. PubMed ID: 31375577
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drugs targeting the particle for arrangement of quaternary structure (PAQosome) and protein complex assembly.
    Pinard M; Moursli A; Coulombe B
    Expert Opin Drug Discov; 2024; 19(1):57-71. PubMed ID: 37840283
    [TBL] [Abstract][Full Text] [Related]  

  • 34. More than folding: localized functions of cytosolic chaperones.
    Young JC; Barral JM; Ulrich Hartl F
    Trends Biochem Sci; 2003 Oct; 28(10):541-7. PubMed ID: 14559183
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The roles of HSP40/DNAJ protein family in neurodegenerative diseases.
    He Y; Wang Z
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2022 Nov; 51(5):640-646. PubMed ID: 36581576
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chaperones-A New Class of Potential Therapeutic Targets in Alzheimer's Disease.
    Batko J; Antosz K; Miśków W; Pszczołowska M; Walczak K; Leszek J
    Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542375
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional specificity of co-chaperone interactions with Hsp90 client proteins.
    Riggs DL; Cox MB; Cheung-Flynn J; Prapapanich V; Carrigan PE; Smith DF
    Crit Rev Biochem Mol Biol; 2004; 39(5-6):279-95. PubMed ID: 15763706
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cofactor Tpr2 combines two TPR domains and a J domain to regulate the Hsp70/Hsp90 chaperone system.
    Brychzy A; Rein T; Winklhofer KF; Hartl FU; Young JC; Obermann WM
    EMBO J; 2003 Jul; 22(14):3613-23. PubMed ID: 12853476
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In silico identification of carboxylate clamp type tetratricopeptide repeat proteins in Arabidopsis and rice as putative co-chaperones of Hsp90/Hsp70.
    Prasad BD; Goel S; Krishna P
    PLoS One; 2010 Sep; 5(9):e12761. PubMed ID: 20856808
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulation of neurodegeneration by molecular chaperones.
    Muchowski PJ; Wacker JL
    Nat Rev Neurosci; 2005 Jan; 6(1):11-22. PubMed ID: 15611723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.